Advertisement
YOU ARE HERE: LAT HomeCollectionsDavid Katz
IN THE NEWS

David Katz

CALIFORNIA | LOCAL
May 13, 1987
A Burbank woman has been indicted for allegedly smuggling cocaine into Terminal Island Federal Correctional Institute to her boyfriend, who is being held on explosives and drug conspiracy charges. The woman, Bonnie Starheim, 46, is accused of taking six grams of cocaine to Donald Ewald, 40, who is awaiting trial after his arrest outside Taft High School in Woodland Hills. He allegedly tried to sell military explosives and 100 grams of PCP to undercover officers.
Advertisement
CALIFORNIA | LOCAL
November 4, 1987
A Reseda woman pleaded guilty Tuesday to helping her Malibu boyfriend swindle investors out of nearly half a million dollars by selling them "partnerships" in phony oil wells. Ann Borrowdale, 35, in pleading guilty in federal court to three counts of mail fraud, acknowledged that she controlled several bank accounts opened with the investors' money and mailed contracts to them.
CALIFORNIA | LOCAL
February 15, 1992
A San Diego couple was sentenced Friday in U.S. District Court for convictions in a series of armed bank robberies last winter. James Wendell Whidden and Margaret Ann Whidden pleaded guilty in October to eight San Diego robberies between Dec. 8, 1989, and Feb. 14, 1990. The Whiddens and a companion were known to law enforcement agents as the "Ninja Bandits" because of the dark clothing, hoods and ski masks they wore. James Whidden was sentenced to 30 years in prison, Assistant U.S. Atty.
CALIFORNIA | LOCAL
January 26, 1989
A Malibu woman who operated a $10-million telemarketing scheme that bilked thousands of people through phony "gift giveaways" was sentenced Wednesday to eight years in prison. Janice Rado, 42, tearfully told U.S. District Judge Ferdinand F. Fernandez that she was sorry for conning her customers and for developing a relationship with a U.S. Postal Service inspector in order to learn how much evidence the government had against her. Assistant U.S. Atty.
BUSINESS
January 1, 1998 | Bloomberg News
Lidak Pharmaceuticals said Bristol-Myers Squibb Co. canceled its license to market Lidak's herpes drug, Lidakol, in North America. "We have no specific explanation for this cancellation," David Katz, Lidak's president and chief executive, said in a statement. The company intends to find new, more profitable ways to market its flagship drug. Shares of the La Jolla-based drug maker rose 23% on Oct. 15 on promising late-stage clinical trials of Lidakol, a topical treatment for acute herpes.
Los Angeles Times Articles
|